Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Robert A Bell, Laramie D. Taylor, Richard L Kravitz

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: To examine how online depression support group members respond to direct-to-consumer (DTC) antidepressant advertising. Methods: Survey of 148 depression forum members, administered via an online questionnaire. Results: Chronicity was high, as 79.1% had received a diagnosis of depression 3 or more years earlier. Respondents reported seeing advertisements for an average of 4.3 of seven brands investigated. A majority rated the information quality of these advertisements as " poor" or " fair." Attitudes toward antidepressant advertisements were neutral (mean: 2.96 on a five-point scale). More than half (52.4%) visited official websites provided in these advertisements, 39.9% had talked with a doctor after seeing an advertisement, 20.3% made an advertisement-induced prescription request, and 25.7% said these advertisements reminded them to take their antidepressants. Amount of attention given to these advertisements correlated positively with belief in the brain chemical imbalance causal model, but belief in this model did not predict prescription requests. Conclusion: Awareness of DTC antidepressant advertisements is high among individuals with depression, but so is skepticism. Practice implications: Among members of an online support group, these advertisements encourage patient-doctor dialogue, prescription requests, and adherence, but might also reduce the acceptability of psychotherapy and encourage doctor switching in a small number of patients.

Original languageEnglish (US)
Pages (from-to)245-250
Number of pages6
JournalPatient Education and Counseling
Volume81
Issue number2
DOIs
StatePublished - Nov 2010

Fingerprint

Antidepressive Agents
Communication
Depression
Physicians
Prescriptions
Self-Help Groups
Psychotherapy
Brain

Keywords

  • Advertisements
  • Advertising
  • Antidepressants
  • Chemical imbalance
  • Depression
  • Direct-to-consumer
  • Drugs
  • Marketing
  • Patient requests
  • Prescription
  • Promotion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians? / Bell, Robert A; Taylor, Laramie D.; Kravitz, Richard L.

In: Patient Education and Counseling, Vol. 81, No. 2, 11.2010, p. 245-250.

Research output: Contribution to journalArticle

@article{2c4d25ff6784435393cbd444429c2995,
title = "Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?",
abstract = "Objective: To examine how online depression support group members respond to direct-to-consumer (DTC) antidepressant advertising. Methods: Survey of 148 depression forum members, administered via an online questionnaire. Results: Chronicity was high, as 79.1{\%} had received a diagnosis of depression 3 or more years earlier. Respondents reported seeing advertisements for an average of 4.3 of seven brands investigated. A majority rated the information quality of these advertisements as {"} poor{"} or {"} fair.{"} Attitudes toward antidepressant advertisements were neutral (mean: 2.96 on a five-point scale). More than half (52.4{\%}) visited official websites provided in these advertisements, 39.9{\%} had talked with a doctor after seeing an advertisement, 20.3{\%} made an advertisement-induced prescription request, and 25.7{\%} said these advertisements reminded them to take their antidepressants. Amount of attention given to these advertisements correlated positively with belief in the brain chemical imbalance causal model, but belief in this model did not predict prescription requests. Conclusion: Awareness of DTC antidepressant advertisements is high among individuals with depression, but so is skepticism. Practice implications: Among members of an online support group, these advertisements encourage patient-doctor dialogue, prescription requests, and adherence, but might also reduce the acceptability of psychotherapy and encourage doctor switching in a small number of patients.",
keywords = "Advertisements, Advertising, Antidepressants, Chemical imbalance, Depression, Direct-to-consumer, Drugs, Marketing, Patient requests, Prescription, Promotion",
author = "Bell, {Robert A} and Taylor, {Laramie D.} and Kravitz, {Richard L}",
year = "2010",
month = "11",
doi = "10.1016/j.pec.2010.01.014",
language = "English (US)",
volume = "81",
pages = "245--250",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

AU - Bell, Robert A

AU - Taylor, Laramie D.

AU - Kravitz, Richard L

PY - 2010/11

Y1 - 2010/11

N2 - Objective: To examine how online depression support group members respond to direct-to-consumer (DTC) antidepressant advertising. Methods: Survey of 148 depression forum members, administered via an online questionnaire. Results: Chronicity was high, as 79.1% had received a diagnosis of depression 3 or more years earlier. Respondents reported seeing advertisements for an average of 4.3 of seven brands investigated. A majority rated the information quality of these advertisements as " poor" or " fair." Attitudes toward antidepressant advertisements were neutral (mean: 2.96 on a five-point scale). More than half (52.4%) visited official websites provided in these advertisements, 39.9% had talked with a doctor after seeing an advertisement, 20.3% made an advertisement-induced prescription request, and 25.7% said these advertisements reminded them to take their antidepressants. Amount of attention given to these advertisements correlated positively with belief in the brain chemical imbalance causal model, but belief in this model did not predict prescription requests. Conclusion: Awareness of DTC antidepressant advertisements is high among individuals with depression, but so is skepticism. Practice implications: Among members of an online support group, these advertisements encourage patient-doctor dialogue, prescription requests, and adherence, but might also reduce the acceptability of psychotherapy and encourage doctor switching in a small number of patients.

AB - Objective: To examine how online depression support group members respond to direct-to-consumer (DTC) antidepressant advertising. Methods: Survey of 148 depression forum members, administered via an online questionnaire. Results: Chronicity was high, as 79.1% had received a diagnosis of depression 3 or more years earlier. Respondents reported seeing advertisements for an average of 4.3 of seven brands investigated. A majority rated the information quality of these advertisements as " poor" or " fair." Attitudes toward antidepressant advertisements were neutral (mean: 2.96 on a five-point scale). More than half (52.4%) visited official websites provided in these advertisements, 39.9% had talked with a doctor after seeing an advertisement, 20.3% made an advertisement-induced prescription request, and 25.7% said these advertisements reminded them to take their antidepressants. Amount of attention given to these advertisements correlated positively with belief in the brain chemical imbalance causal model, but belief in this model did not predict prescription requests. Conclusion: Awareness of DTC antidepressant advertisements is high among individuals with depression, but so is skepticism. Practice implications: Among members of an online support group, these advertisements encourage patient-doctor dialogue, prescription requests, and adherence, but might also reduce the acceptability of psychotherapy and encourage doctor switching in a small number of patients.

KW - Advertisements

KW - Advertising

KW - Antidepressants

KW - Chemical imbalance

KW - Depression

KW - Direct-to-consumer

KW - Drugs

KW - Marketing

KW - Patient requests

KW - Prescription

KW - Promotion

UR - http://www.scopus.com/inward/record.url?scp=77957286739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957286739&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2010.01.014

DO - 10.1016/j.pec.2010.01.014

M3 - Article

VL - 81

SP - 245

EP - 250

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 2

ER -